Nanomaterials: small particles show huge possibilities for cancer immunotherapy
Z Chen, Z Yue, K Yang, S Li - Journal of Nanobiotechnology, 2022 - Springer
With the economy's globalization and the population's aging, cancer has become the
leading cause of death in most countries. While imposing a considerable burden on society …
leading cause of death in most countries. While imposing a considerable burden on society …
Recent Advances in Carbon‐Nitrogen/Carbon‐Oxygen Bond Formation Under Transition‐Metal‐Free Conditions
Carbon‐heteroatom bond formation under transition‐metal free conditions provides a
powerful synthetic alternative for the efficient synthesis of valuable molecules. In particular …
powerful synthetic alternative for the efficient synthesis of valuable molecules. In particular …
Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology
EL Reinherz, W Hwang… - Proceedings of the …, 2023 - National Acad Sciences
T cell receptors (TCR) on cytolytic T lymphocytes (CTLs) recognize" foreign" antigens bound
in the groove of major histocompatibility complex (MHC) molecules (H-2 in mouse and HLA …
in the groove of major histocompatibility complex (MHC) molecules (H-2 in mouse and HLA …
CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity
P Baumgaertner, J Schmidt, CM Costa-Nunes… - Frontiers in …, 2022 - frontiersin.org
Recruitment and activation of CD8 T cells occur through specific triggering of T cell receptor
(TCR) by peptide-bound human leucocyte antigen (HLA) ligands. Within the generated …
(TCR) by peptide-bound human leucocyte antigen (HLA) ligands. Within the generated …
Low TCR Binding Strength Results in Increased Progenitor-like CD8+ Tumor-Infiltrating Lymphocytes
ZLZ Hay, JR Knapp, RE Magallon, BP O'Connor… - Cancer Immunology …, 2023 - AACR
T-cell receptor (TCR) binding strength to peptide-MHC antigen complex influences
numerous T-cell functions. However, the vast diversity of a polyclonal T-cell repertoire for …
numerous T-cell functions. However, the vast diversity of a polyclonal T-cell repertoire for …
Aspirin induces immunogenic cell death and enhances cancer immunotherapy in colorectal cancer
J Lei, Z Zhou, J Fang, Z Sun, M He, B He… - International …, 2023 - Elsevier
The use of aspirin is associated with reduced incidence of colorectal cancer (CRC).
However, the detailed mechanism remains unclear. In this study, we reported that colon …
However, the detailed mechanism remains unclear. In this study, we reported that colon …
Autoimmune susceptible HLA class II motifs facilitate the presentation of modified neoepitopes to potentially autoreactive T cells
AK Moustakas, H Nguyen, EA James… - Cellular …, 2023 - Elsevier
Rheumatoid arthritis (RA), multiple sclerosis (MS), type 1 diabetes (T1D), and celiac disease
(CD), are strongly associated with susceptible HLA class II haplotypes. The peptide-binding …
(CD), are strongly associated with susceptible HLA class II haplotypes. The peptide-binding …
Techniques for Theoretical Prediction of Immunogenic Peptides
R Friedman - Encyclopedia, 2024 - mdpi.com
Definition Small peptides are an important component of the vertebrate immune system.
They are important molecules for distinguishing proteins that originate in the host from …
They are important molecules for distinguishing proteins that originate in the host from …
Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?
Q Liu, P Wu, J Lei, P Bai, P Zhong, M Yang… - International Journal of …, 2024 - Elsevier
Over the past few decades, research on cancer immunotherapy has firmly established
immune cells as key players in effective cancer treatment. Peptide vaccines directly targeting …
immune cells as key players in effective cancer treatment. Peptide vaccines directly targeting …
Determinants of tumor immune evasion: the role of T cell exposed motif frequency and mutant amino acid exposure
EJ Homan, RD Bremel - Frontiers in Immunology, 2023 - frontiersin.org
Few neoepitopes detected in tumor biopsies are immunogenic. Tumor-specific T cell
responses require both the presentation of an epitope that differs from wildtype and the …
responses require both the presentation of an epitope that differs from wildtype and the …